The Edge Singapore
iX Biopharma
Broker's Digest: Spotify, NetLink NBN Trust, TDCX, iX Biopharma, StarHub
Premium
Broker's Calls
Broker's Digest: Spotify, NetLink NBN Trust, TDCX, iX Biopharma, StarHub
by The Edge Singapore• October 06, 2022
PhillipCap slashes target price on iX Biopharma, but maintains ‘buy’ call
Premium
Broker's Calls
PhillipCap slashes target price on iX Biopharma, but maintains ‘buy’ call
by Lim Hui Jie• October 03, 2022
iX Biopharma launches sublingual dexmedetomidine wafer to treat agitation in dementia and other indications
Premium
Medtech
iX Biopharma launches sublingual dexmedetomidine wafer to treat agitation in dementia and other indications
by The Editor• August 29, 2022
iX Biopharma reports loss for FY2022 despite eight-fold rise in revenue
Premium
Results
iX Biopharma reports loss for FY2022 despite eight-fold rise in revenue
by Felicia Tan• August 23, 2022
iX Biopharma to raise $2.7 mil placing out new shares at premium to current market price
Premium
Equity raising
iX Biopharma to raise $2.7 mil placing out new shares at premium to current market price
by The Edge Singapore• July 12, 2022
iX Biopharma reverses from losses to net profit of $3.7 mil in 1HFY2022 from out-licensing of Wafermine
Premium
Results
iX Biopharma reverses from losses to net profit of $3.7 mil in 1HFY2022 from out-licensing of Wafermine
by Felicia Tan• February 11, 2022
iX Biopharma aims for stronger growth momentum with Seelos licensing deal
Premium
Corporate moves
iX Biopharma aims for stronger growth momentum with Seelos licensing deal
by Chloe Lim• January 13, 2022
iX Biopharma 'warming up' with new outlicensing agreement with Seelos Therapeutics: PhillipCapital
Premium
Broker's Calls
iX Biopharma 'warming up' with new outlicensing agreement with Seelos Therapeutics: PhillipCapital
by Chloe Lim• December 01, 2021
Trending Now
OCBC opens 20,000 sq ft lifestyle and banking space at Wisma Atria, its second-largest after OCBC Centre
Temasek's failed investment in FTX is a 'pain' but let's 'fry other fishes', says Ho Ching
Chip Eng Seng chairman Tang makes 72 cents per share offer to increase stake
Copen Grand fully sold, with remaining units snapped up by second-time buyers
CLSA upgrades CLAR and Keppel DC REIT, issues downgrades on seven other S-REITs
iX Biopharma inks exclusive agreement with Seelos worth up US$239 mil
Premium
Healthcare
iX Biopharma inks exclusive agreement with Seelos worth up US$239 mil
by The Edge Singapore • November 24, 2021
iX Biopharma signs agreement with China Resources Pharmaceutical Commercial Group to distribute Wafesil in China
Premium
Deals, joint ventures & alliances
iX Biopharma signs agreement with China Resources Pharmaceutical Commercial Group to distribute Wafesil in China
by Felicia Tan• September 30, 2021
Subscribe to our newsletter
Never miss out on important financial news and get daily updates today
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.